Literature DB >> 12177168

Activation of phospholipase D-2 by P2X(7) agonists in rat submandibular gland acini.

Encarnación Pérez-Andrés1, María Fernández-Rodriguez, Mónica González, Ana Zubiaga, Ainara Vallejo, Itxaso García, Carlos Matute, Stéphanie Pochet, Jean Paul Dehaye, Miguel Trueba, Aida Marino, Antonio Gómez-Muñoz.   

Abstract

Exogenous ATP stimulated phospholipase D (PLD), but not sphingomyelinase in rat submandibular gland (SMG) acini. PLD activation was dependent upon extracellular Ca(2+) and did not involve intracellular Ca(2+) mobilization or phosphoinositide-specific phospholipase C activation. ATP-stimulated PLD was attenuated by inhibition or downregulation of protein kinase C (PKC). PLD activation was fully blocked by the cytosolic phospholipase A(2) (PLA(2)) inhibitor ONO-RS-082 and partially attenuated by the selective Ca(2+)-dependent cytosolic PLA(2) inhibitor, arachidonyl trifluoromethylketone (AACOCF(3)), or by bromoenol lactone, an inhibitor of Ca(2+)-independent cytosolic PLA(2). Magnesium, which decreases the concentration of ATP(4-), and nickel, which blocks nonspecific cation channels coupled to purinergic receptors, inhibited PLD activation by ATP. Using reverse transcription-polymerase chain reaction and Northern blotting techniques, we demonstrated that the PLD isoform stimulated by ATP was PLD-2. Among various ATP analogs, only the P2Z/P2X(7) purinergic receptor agonist benzoyl-benzoyl ATP stimulated PLD-2. The response to ATP was inhibited by the nonselective P2X purinergic antagonist suramin and by oxidized ATP, a potent P2Z/P2X(7) receptor antagonist. It is concluded that in rat SMG acinar cells, PLD-2 is upregulated by exogenous ATP through a mechanism involving Ca(2+) influx, cytosolic PLA(2), and PKC. Also, the data suggest an involvement of P2X(7) receptors in PLD-2 stimulation by ATP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177168

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Lipid metabolism modulation by the P2X7 receptor in the immune system and during the course of infection: new insights into the old view.

Authors:  Helio Miranda Costa-Junior; Camila Marques-da-Silva; Flávia Sarmento Vieira; Leonardo Campos Monção-Ribeiro; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2011-08-16       Impact factor: 3.765

Review 2.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

3.  Wounding sheets of epithelial cells activates the epidermal growth factor receptor through distinct short- and long-range mechanisms.

Authors:  Ethan R Block; Jes K Klarlund
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

4.  Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor.

Authors:  Anne N Shemon; Ronald Sluyter; Arthur D Conigrave; James S Wiley
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

Review 5.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

6.  Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.

Authors:  Patricia Gangoiti; Maria H Granado; Alicia Alonso; Félix M Goñi; Antonio Gómez-Muñoz
Journal:  Transl Oncogenomics       Date:  2008-04-10

Review 7.  P2X7 Interactions and Signaling - Making Head or Tail of It.

Authors:  Robin Kopp; Anna Krautloher; Antonio Ramírez-Fernández; Annette Nicke
Journal:  Front Mol Neurosci       Date:  2019-08-07       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.